Susan Soto

2.4k total citations
35 papers, 1.2k citations indexed

About

Susan Soto is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Susan Soto has authored 35 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 20 papers in Pathology and Forensic Medicine and 14 papers in Immunology. Recurrent topics in Susan Soto's work include Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Susan Soto is often cited by papers focused on Chronic Lymphocytic Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Susan Soto collaborates with scholars based in United States, Malaysia and India. Susan Soto's co-authors include Adrian Wiestner, Xin Tian, Janet Valdez, Mohammed Farooqui, Jay N. Lozier, Katherine R. Calvo, Constance M. Yuan, Inhye E. Ahn, Maryalice Stetler‐Stevenson and Irina Marić and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Susan Soto

32 papers receiving 1.2k citations

Peers

Susan Soto

GENET

PFM

HEMAT

IMMUN

ONCOL

Loïc Ysebaert France

Philippe Travade France

Brigitte Dreyfus France

Ben Kennedy United Kingdom

Surender Juneja Australia

Michael J. Clemente United States

Toshiki Yamada Japan

Masamitsu Karasawa Japan

Anastasios Raptis United States

Takafumi Matsushima Japan

Loïc Ysebaert France

Susan Soto

914 ×1.1

GENET

783 ×1.4

PFM

430 ×0.9

HEMAT

445 ×1.1

IMMUN

308 ×1.4

ONCOL

Citations per year, relative to Susan Soto Susan Soto (= 1×) peers Loïc Ysebaert

Countries citing papers authored by Susan Soto

Since Specialization

Citations

This map shows the geographic impact of Susan Soto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Soto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Soto more than expected).

Fields of papers citing papers by Susan Soto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Soto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Soto. The network helps show where Susan Soto may publish in the future.

Co-authorship network of co-authors of Susan Soto

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Soto. A scholar is included among the top collaborators of Susan Soto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Soto. Susan Soto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yuan, Constance M., Hao‐Wei Wang, Inhye E. Ahn, et al.. (2025). A Decade of Ibrutinib for CLL with and without TP53 Aberration: Final Report on an Investigator-Sponsored Phase 2 Study. Blood.

Brofferio, Alessandra, Jeanine Superata, Susan Soto, et al.. (2024). Cardiac Monitoring of Patients on Btki for Chronic Lymphocytic Leukemia. Blood. 144(Supplement 1). 6787–6787.

Chen, Jonathan, Erika M. Gaglione, Chingiz Underbayev, et al.. (2023). CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy. Clinical Cancer Research. 29(18). 3612–3621. 11 indexed citations

Ahn, Inhye E., Xin Tian, David Ipe, et al.. (2020). Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib: Development and Validation of a Four-Factor Prognostic Model. Journal of Clinical Oncology. 39(6). 576–585. 56 indexed citations

Pleyer, Christopher, Jeffrey I. Cohen, Susan Soto, et al.. (2019). Response to the Shingrix Varicella Zoster Virus (VZV) Vaccine in Patients with Chronic Lymphocytic Leukemia (CLL) That Are Treatment Naive or Treated with a Bruton's Tyrosine Kinase Inhibitor (BTK-I). Blood. 134(Supplement_1). 3053–3053. 7 indexed citations

Aue, Georg, Clare Sun, Delong Liu, et al.. (2018). Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. The Journal of Immunology. 201(7). 1967–1974. 21 indexed citations

Skarzynski, Martin, Carsten Utoft Niemann, Yuh Shan Lee, et al.. (2015). Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy. Clinical Cancer Research. 22(1). 86–95. 62 indexed citations

Farooqui, Mohammed, Janet Valdez, Susan Soto, et al.. (2015). Atrial Fibrillation in CLL/SLL Patients on Ibrutinib. Blood. 126(23). 2933–2933. 33 indexed citations

Farooqui, Mohammed, Janet Valdez, Susan Soto, et al.. (2015). Single Agent Ibrutinib in CLL/SLL Patients with and without Deletion 17p. Blood. 126(23). 2937–2937. 7 indexed citations

10.

Ahn, Inhye E., Mohammed Farooqui, Yuh Shan Lee, et al.. (2015). Risk-Adapted Induction and Maintenance with Ofatumumab in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL). Blood. 126(23). 1750–1750. 2 indexed citations

11.

Sun, Clare, Xin Tian, Yuh Shan Lee, et al.. (2015). Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 126(19). 2213–2219. 166 indexed citations

12.

Farooqui, Mohammed, Georg Aue, Janet Valdez, et al.. (2013). Single Agent Ibrutinib (PCI-32765) Achieves Equally Good and Durable Responses In Chronic Lymphocytic Leukemia (CLL) Patients With and Without Deletion 17p. Blood. 122(21). 673–673. 15 indexed citations

13.

Herman, Sarah E. M., Rashida Z. Mustafa, Sabrina Martyr, et al.. (2013). Effective Inhibition Of Tumor Microenvironment Interactions In CLL Patients Treated With The BTK Inhibitor Ibrutinib Results In Sustained Inhibition Of Tumor Proliferation and Survival Pathways. Blood. 122(21). 118–118.

14.

Aue, Georg, Mohammed Farooqui, Jade Jones, et al.. (2013). In Patients With Chronic Lymphocytic Leukemia (CLL) Ibrutinib Effectively Reduces Clonal IgM Paraproteins and Serum Free Light Chains While Increasing Normal IgM, IgA Serum Levels, Suggesting a Nascent Recovery Of Humoral Immunity. Blood. 122(21). 4182–4182. 6 indexed citations

15.

Olnes, Matthew J., Phillip Scheinberg, Katherine R. Calvo, et al.. (2012). Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia. New England Journal of Medicine. 367(1). 11–19. 345 indexed citations

16.

Aue, Georg, Jay N. Lozier, Xin Tian, et al.. (2011). Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. American Journal of Hematology. 86(10). 835–840. 31 indexed citations

17.

Olnes, Matthew J., Phillip Scheinberg, Katherine R. Calvo, et al.. (2011). Eltrombopag Can Stimulate Trilineage Hematopoiesis with Transfusion Independence in Patients with Refractory Severe Aplastic Anemia: Results From a Phase II Trial. Blood. 118(21). 54–54. 3 indexed citations

18.

Aue, Georg, Susan Soto, Janet Valdez, et al.. (2010). Phase II Trial of Pulse Dosed Lenalidomide In Previously Treated Chronic Lymphocytic Leukemia. Blood. 116(21). 1383–1383. 7 indexed citations

19.

Aue, Georg, Susan Soto, Janet Valdez, et al.. (2009). A Phase II Trial of Pulse Dosing Lenalidomide: 3 Weeks On 3 Weeks off in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.. Blood. 114(22). 3427–3427. 2 indexed citations

20.

Aue, Georg, Ndegwa Njuguna, Xin Tian, et al.. (2008). Lenalidomide Induced Cytokine Release Syndrome in Chronic Lymphocytic Leukemia (CLL): Clinical and Laboratory Correlates of Immune Activation.. Blood. 112(11). 2099–2099. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact